Jiali Dong

Development of a Humanized VHH Based Recombinant Antibody Targeting Claudin 18.2 Positive Cancers

Yanshan Huang, Yongfeng Ding, Yongliang Fang, 2022, Frontiers in Immunology.

Development and comparison of 68Ga/18F/64Cu-labeled nanobody tracers probing Claudin18.2

J. Liu, G. Huang, Yanshan Huang, 2022, Molecular therapy oncolytics.